| Hait, William N; Rubin, Eric; Goodin, Susan (2005) Tubulin-targeting agents. Cancer Chemother Biol Response Modif 22:35-59 |
| Hait, William N; Rubin, Eric; Goodin, Susan (2003) Tubulin-targeting agents. Cancer Chemother Biol Response Modif 21:41-67 |
| Hait, William N; Rubin, Eric; Goodin, Susan (2002) Tubulin-targeting agents. Cancer Chemother Biol Response Modif 20:71-97 |
| Hait, W N; Rubin, E; Goodin, S (2001) Tubulin targeting agents. Cancer Chemother Biol Response Modif 19:59-83 |
| Saleem, A; Edwards, T K; Rasheed, Z et al. (2000) Mechanisms of resistance to camptothecins. Ann N Y Acad Sci 922:46-55 |
| Edwards, T K; Saleem, A; Shaman, J A et al. (2000) Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I. J Biol Chem 275:36181-8 |
| Pond, C D; Li, X G; Rubin, E H et al. (1999) Effects of mutations in the F361 to R364 region of topoisomerase I (Topo I), in the presence and absence of 9-aminocamptothecin, on the Topo I-DNA interaction. Anticancer Drugs 10:647-53 |
| Haluska Jr, P; Saleem, A; Rasheed, Z et al. (1999) Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein. Nucleic Acids Res 27:2538-44 |
| Haluska Jr, P; Rubin, E H (1998) A role for the amino terminus of human topoisomerase I. Adv Enzyme Regul 38:253-62 |
| Haluska Jr, P; Saleem, A; Edwards, T K et al. (1998) Interaction between the N-terminus of human topoisomerase I and SV40 large T antigen. Nucleic Acids Res 26:1841-7 |
Showing the most recent 10 out of 14 publications
